Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6656)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2014 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ishiguro H, Kimura M, Takeyama H. Role of microRNAs in gastric cancer. World J Gastroenterol 2014; 20(19): 5694-5699 [PMID: 24914330 DOI: 10.3748/wjg.v20.i19.5694] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5694.htm |
| Number | Citing Articles |
| 1 |
Navid Shomali, Behzad Mansoori, Ali Mohammadi, Naghmeh Shirafkan, Mehri Ghasabi, Behzad Baradaran. MiR-146a functions as a small silent player in gastric cancer. Biomedicine & Pharmacotherapy 2017; 96: 238 doi: 10.1016/j.biopha.2017.09.138
|
| 2 |
Xiangfu Ding, Jingjing Liu, Tianzhou Liu, Zhiming Ma, Dacheng Wen, Jiaming Zhu. miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer Medicine 2017; 6(6): 1301 doi: 10.1002/cam4.1008
|
| 3 |
Shagun Sharma, Neelam Saini. A Systematic Review: Role of miRNA in Gastric Cancer Risk, Onset, and Progression. Apollo Medicine 2023; 20(4): 384 doi: 10.4103/am.am_45_23
|
| 4 |
Yoshihisa Tokumaru, Toshihiro Tajirika, Nobuhiko Sugito, Yuki Kuranaga, Haruka Shinohara, Takuya Tsujino, Nobuhisa Matsuhashi, Manabu Futamura, Yukihiro Akao, Kazuhiro Yoshida. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase. International Journal of Molecular Sciences 2019; 20(7): 1697 doi: 10.3390/ijms20071697
|
| 5 |
Nazanin Khayam, Hamideh Rouhani Nejad, Fatemeh Ashrafi, Mohsen Abolhassani. Expression Profile of miRNA-17-3p and miRNA-17-5p Genes in Gastric Cancer Patients with Helicobacter pylori Infection. Journal of Gastrointestinal Cancer 2021; 52(1): 130 doi: 10.1007/s12029-019-00319-5
|
| 6 |
Mahsa Fakeri, Shabnam Koulaeizadeh, Seyed Masoud Armandzadeh, Elmira Aboutalebi Vand Beilankouhi, Mohammad Valilo, Mohammad Reza Alivand. Involvement of miRNA-337 in Various Cancers. Current Cancer Therapy Reviews 2024; 20(2): 188 doi: 10.2174/1573394719666230518112114
|
| 7 |
Qian Li, Nina Wang, Hong Wei, Chao Li, Jing Wu, Guibin Yang. miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6. Digestive Diseases and Sciences 2016; 61(12): 3486 doi: 10.1007/s10620-016-4309-9
|
| 8 |
Federica Rao, Flavio Rizzolio, Clara Rizzardi, Tiziana Perin, Vincenzo Canzonieri. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 175 doi: 10.1007/978-3-030-04861-7_11
|
| 9 |
Valerio Gristina, Nadia Barraco, Antonio Galvano, Daniele Fanale, Maria La Mantia, Marc Peeters, Albert J. ten Tije, Antonio Russo, Jhony Alberto De La Cruz Vargas. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 559 doi: 10.1007/978-3-030-56051-5_35
|
| 10 |
Ji Min Choi, Sang Gyun Kim. Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(4): 256 doi: 10.7704/kjhugr.2021.0042
|
| 11 |
Katie A. Lloyd, Andrew R. Moore, Bryony N. Parsons, Adrian O'Hara, Malcolm Boyce, Graham J. Dockray, Andrea Varro, D. Mark Pritchard. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1. Oncotarget 2016; 7(29): 45462 doi: 10.18632/oncotarget.9990
|
| 12 |
Weihua Huang, Huifen Li, Rongcheng Luo. RETRACTED ARTICLE: The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0366-1
|
| 13 |
Dedong Ma, Hongxiu Lu, Yiqing Qu, Weijiang Fu, Zhe Ma. Developing an effective therapeutic by delivery of synthetic microRNA-520e in lung cancer treatment. Biomedicine & Pharmacotherapy 2015; 69: 249 doi: 10.1016/j.biopha.2014.12.009
|
| 14 |
Hege Marie Vedeld, Ajay Goel, Guro E. Lind. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Seminars in Cancer Biology 2018; 51: 36 doi: 10.1016/j.semcancer.2017.12.004
|
| 15 |
Longtao Huangfu, Biao Fan, Gangjian Wang, Xuejun Gan, Shanshan Tian, Qifei He, Qian Yao, Jinyao Shi, Xiaomei Li, Hong Du, Xiangyu Gao, Xiaofang Xing, Jiafu Ji. Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-021-00802-8
|
| 16 |
Mingxuan Li, Zhenrun Li, Peilin Wang, Qiang Ma. A novel bimetallic MXene derivative QD-based ECL sensor for miRNA-27a-3p detection. Biosensors and Bioelectronics 2023; 228: 115225 doi: 10.1016/j.bios.2023.115225
|
| 17 |
Muhammad Abbas, Alessia Faggian, Dahiru Nasiru Sintali, Ghulam Jilany Khan, Shagufta Naeem, Meiqi Shi, Chen Dingding. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018; 103: 1688 doi: 10.1016/j.biopha.2018.04.178
|
| 18 |
Zhi-hao Yu, Mei Cao, Yuan-xiao Wang, Shi-ying Yan, Li-ting Qing, Cheng-meng Wu, Shu Li, Tian-yi Li, Qian Chen, Jian Zhao. Urolithin A Attenuates Helicobacter pylori-Induced Damage In Vivo. Journal of Agricultural and Food Chemistry 2022; 70(38): 11981 doi: 10.1021/acs.jafc.2c03711
|
| 19 |
Dan Zou, Ling Xu, Heming Li, Yanju Ma, Yuehua Gong, Tianshu Guo, Zhitao Jing, Xiuying Xu, Ye Zhang. Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer. Critical Reviews in Microbiology 2019; 45(2): 239 doi: 10.1080/1040841X.2019.1575793
|
| 20 |
Xiangqian Zhang, Min Zhang, Qingqing Guo, Xiaoyi Hu, Zhenghao Zhao, Lei Ni, Liying Liu, Xiaofei Wang, Zhenzhen Wang, Dongdong Tong, Su’e Chang, Youlong Cao, Chen Huang. MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression. Anti-Cancer Drugs 2019; 30(8): 803 doi: 10.1097/CAD.0000000000000776
|
| 21 |
Jaewoo Lim, Jin-Seong Hwang, Seung Beom Seo, Byunghoon Kang, Soojin Jang, Seong Uk Son, Jisun Ki, Jang-Seong Kim, Taejoon Kang, Juyeon Jung, Tae-Su Han, Eun-Kyung Lim. Janus hydrogel-based fuel stimulant powered amplification for multiple detections of miRNA biomarkers in gastric cancer. Chemical Engineering Journal 2022; 448: 137637 doi: 10.1016/j.cej.2022.137637
|
| 22 |
Liang Yu, Jun Chen, Yu Liu, Zengfeng Zhang, Shaobin Duan. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. Cancer Biomarkers 2017; 21(1): 105 doi: 10.3233/CBM-170310
|
| 23 |
MINGHUI XUE, LUNDE ZHAO, FANG YANG, ZHENJUAN LI, GUANGYAN LI. MicroRNA-145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression. Molecular Medicine Reports 2016; 13(1): 1033 doi: 10.3892/mmr.2015.4609
|
| 24 |
Bopei Li, Liang Liang, Yeyang Chen, Jinlu Liu, Zhen Wang, Yuantian Mao, Kun Zhao, Junqiang Chen. Circ_0008287 promotes immune escape of gastric cancer cells through impairing microRNA-548c-3p-dependent inhibition of CLIC1. International Immunopharmacology 2022; 111: 108918 doi: 10.1016/j.intimp.2022.108918
|
| 25 |
Filipa Macedo, Kátia Ladeira, Adhemar Longatto-Filho, Sandra F. Martins. Editor’s Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker. European Medical Journal 2018; : 42 doi: 10.33590/emj/10313567
|
| 26 |
Mostafa Khafaei, Ehsan Rezaie, Ali Mohammadi, Payam Shahnazi Gerdehsang, Sara Ghavidel, Sepideh Kadkhoda, Atieh Zorrieh Zahra, Narjes Forouzanfar, Hossein Arabameri, Mahmood Tavallaie. miR‐9: From function to therapeutic potential in cancer. Journal of Cellular Physiology 2019; 234(9): 14651 doi: 10.1002/jcp.28210
|
| 27 |
Yihua Pei, Zhiteng Tang, Minjing Cai, Qin Yao, Bozhen Xie, Xin Zhang. The E2F3/miR-125a/DKK3 regulatory axis promotes the development and progression of gastric cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0930-y
|
| 28 |
Jinglin Zhang, Yuhang Zhou, Tingting Huang, Feng Wu, Yi Pan, Yujuan Dong, Yan Wang, Aden K. Y. Chan, Liping Liu, Johnny S. H. Kwan, Alvin H. K. Cheung, Chi Chun Wong, Angela K. F. Lo, Alfred S. L. Cheng, Jun Yu, Kwok Wai Lo, Wei Kang, Ka Fai To. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. Oncogene 2019; 38(1): 33 doi: 10.1038/s41388-018-0430-x
|
| 29 |
Tairan Wang, Yan Jin, Mengyao Wang, Boya Chen, Jinyu Sun, Jiaying Zhang, Hui Yang, Xinyao Deng, Xingyue Cao, Lidong Wang, Yuanyuan Tang. SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00812-z
|
| 30 |
Doaa Fathi, Mohammed S. Elballal, Ahmed E. Elesawy, Ahmed I. Abulsoud, Ahmed Elshafei, Elsayed G.E. Elsakka, Ahmed Ismail, Hesham A. El-Mahdy, Mahmoud A. Elrebehy, Ahmed S. Doghish. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. Life Sciences 2023; 322: 121667 doi: 10.1016/j.lfs.2023.121667
|
| 31 |
Rachel E. Sexton, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Maria Diab, Asfar S. Azmi. Gastric Cancer Heterogeneity and Clinical Outcomes. Technology in Cancer Research & Treatment 2020; 19: 153303382093547 doi: 10.1177/1533033820935477
|
| 32 |
JIAN CHEN, DI SUN, HONGJIN CHU, ZHAOHUA GONG, CHENGLIN ZHANG, BENJIAO GONG, YAN LI, NING LI, LIXIN JIANG. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction. Oncology Reports 2015; 33(6): 2963 doi: 10.3892/or.2015.3935
|
| 33 |
Wei Dong, Jingwu Li, Xiaoliu Dong, Wenjian Shi, Yu Zhang, Yongliang Liu. MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma. OncoTargets and Therapy 2021; : 3109 doi: 10.2147/OTT.S307138
|
| 34 |
Zihan Rao, Yuqin Xu, Zihan He, Juan Wang, Huanhong Ji, Zhongwei Zhang, Jianming Zhou, Tong Zhou, Huai Wang. Carcinogenicity of nicotine and signal pathways in cancer progression: a review. Environmental Chemistry Letters 2024; 22(1): 239 doi: 10.1007/s10311-023-01668-1
|
| 35 |
Jianhong Wu, Guangxin Li, Yongliang Yao, Zeyou Wang, Wangwei Sun, Jianjun Wang. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers 2015; 20(1): 58 doi: 10.3109/1354750X.2014.992812
|
| 36 |
György Miklós Buzás. Helicobacter pylori– 2014. Orvosi Hetilap 2015; 156(6): 203 doi: 10.1556/OH.2015.30097
|
| 37 |
Ying Yang, Chao Tian, Wen-Jian Meng. Cancer Stem Cells: New Horizons in Cancer Therapies. 2020; : 339 doi: 10.1007/978-981-15-5120-8_18
|
| 38 |
Kubra A. Coskun, Bercem Yeman Kıyak, Kezban Ucar Cifci, Elif Kadioglu, Nazlican Yurekli, Yusuf Tutar. Involvement of Metabolites and Non-coding RNAs in Diseases. Current Pharmaceutical Biotechnology 2023; 24(7): 889 doi: 10.2174/1389201023666220921091240
|
| 39 |
Zhenxian Xiang, Min Sun, Zewei Yuan, Chunxiao Zhang, Jun Jiang, Sihao Huang, Bin Xiong. Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis. Oncotarget 2018; 9(1): 1279 doi: 10.18632/oncotarget.22633
|
| 40 |
Marie-Elodie Spaety, Alexandre Gries, Amandine Badie, Aina Venkatasamy, Benoit Romain, Christophe Orvain, Kazuyoshi Yanagihara, Koji Okamoto, Alain C. Jung, Georg Mellitzer, Sébastien Pfeffer, Christian Gaiddon. HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway. Cancers 2019; 11(11): 1747 doi: 10.3390/cancers11111747
|
| 41 |
Yongchao Liu, Jing Zhao, Wenhong Zhang, Jun Gan, Chengen Hu, Guangjian Huang, Ying Zhang. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Scientific Reports 2015; 5(1) doi: 10.1038/srep10159
|
| 42 |
Ning-Bo Hao, Ya-Fei He, Xiao-Qin Li, Kai Wang, Rui-Ling Wang. The role of miRNA and lncRNA in gastric cancer. Oncotarget 2017; 8(46): 81572 doi: 10.18632/oncotarget.19197
|
| 43 |
Chengjun Sui, Feng Xu, Weifeng Shen, Li Geng, Feng Xie, Binghua Dai, Jiongjiong Lu, Minfeng Zhang, Jiamei Yang. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET. Tumor Biology 2015; 36(3): 1511 doi: 10.1007/s13277-014-2679-1
|
| 44 |
Bo-Shih Huang, Chih-Ta Chen, Chao-Chi Yeh, Ting-Yu Fan, Fang-Yun Chen, Jyh-Ming Liou, Chia-Tung Shun, Ming-Shiang Wu, Lu-Ping Chow, Nandakumar Natarajan. miR-21 Targets ASPP2 to Inhibit Apoptosis via CHOP-Mediated Signaling in Helicobacter pylori-Infected Gastric Cancer Cells. Journal of Oncology 2023; 2023: 1 doi: 10.1155/2023/6675265
|
| 45 |
Hui Li, Guoqing Liu, Ke Pan, Xiongying Miao, Yong Xie. Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1. Oncotarget 2017; 8(56): 95880 doi: 10.18632/oncotarget.21431
|
| 46 |
Shaleniprieya Muniandy, Ling Few, Boon Khoo, Siti Hassan, Get Yvonne‑Τee, Wei See Too. Dysregulated expression of miR‑367 in disease development and its prospects as a therapeutic target and diagnostic biomarker (Review). Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1673
|
| 47 |
Mohammad Reza Bayatiani, Azam Ahmadi, Reza Aghabozorgi, Fatemeh Seif. Concomitant Up-Regulation of Hsa- Mir-374 and Down-Regulation of Its Targets, GSK-3β and APC, in Tissue Samples of Colorectal Cancer. Reports of Biochemistry and Molecular Biology 2021; 9(4): 408 doi: 10.52547/rbmb.9.4.408
|
| 48 |
Hao Zhou, Hongyan Liu, Miao Jiang, Shaoren Zhang, Junfeng Chen, Xiaoming Fan. Targeting MicroRNA-21 Suppresses Gastric Cancer Cell Proliferation and Migration via PTEN/Akt Signaling Axis. Cell Transplantation 2019; 28(3): 306 doi: 10.1177/0963689719825573
|
| 49 |
Yi Hua Low, Celestine Jia Ling Loh, Daniel Yang Yao Peh, Axel Jun Ming Chu, Shuting Han, Han Chong Toh. Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1202117
|
| 50 |
Azam Ahmadi, Mohamd Reza Bayatiani, Fatemeh Seif, Jamshid Ansari, Parisa Rashidi, Mona Moghadasi, Mobarakeh Etemadi. Evaluation of Radiotherapy on miR-374 Gene Expression in Colorectal Cancer Patient Blood Samples. Reports of Biochemistry and Molecular Biology 2022; 10(4): 614 doi: 10.52547/rbmb.10.4.614
|
| 51 |
Minjeong Jang, Giwoong Choi, Yoon Young Choi, Jae Eun Lee, Jik-Han Jung, Seung Won Oh, Dai Hoon Han, Haeshin Lee, Ji-Ho Park, Jae-Ho Cheong, Pilnam Kim. Extracellular vesicle (EV)-polyphenol nanoaggregates for microRNA-based cancer diagnosis. NPG Asia Materials 2019; 11(1) doi: 10.1038/s41427-019-0184-0
|
| 52 |
Abdullatif Akbari, Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Zeinab Fathi, Fatemeh Aziziyan, Ali Yousefi Rad, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Yalda Malekzadegan. Autophagy induced by Helicobacter Pylori infection can lead to gastric cancer dormancy, metastasis, and recurrence: new insights. Human Cell 2023; 37(1): 139 doi: 10.1007/s13577-023-00996-2
|
| 53 |
Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang. miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway. Bioscience, Biotechnology, and Biochemistry 2017; 81(1): 119 doi: 10.1080/09168451.2016.1238294
|
| 54 |
Maggie R. Williams, Robert D. Stedtfeld, James M. Tiedje, Syed A. Hashsham. MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01896
|
| 55 |
Di Wu, Tianyu Xie, Shuo Li, Yixun Lu, Xiongguang Li, Qiying Song, Benlong Zhang, Liyu Zhang, Xinxin Wang. Pterostilbene Affects Gastric Cancer Cell Proliferation and Epithelial Mesenchymal Transition (EMT) by Targeting miR-126-3p. Science of Advanced Materials 2022; 14(1): 80 doi: 10.1166/sam.2022.4195
|
| 56 |
Yingying Xu, Guiping Wang, Wenqing Hu, Songbing He, Dandan Li, Ping Chen, Jinjie Zhang, Yongshun Gao, Duonan Yu, Liang Zong. Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients. Medicine 2022; 101(19): e29242 doi: 10.1097/MD.0000000000029242
|
| 57 |
HUI LI, JIASHUN LUO, BIN XU, KAIJUN LUO, JUAN HOU. MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells. Molecular Medicine Reports 2015; 12(2): 3121 doi: 10.3892/mmr.2015.3749
|
| 58 |
Taro Sugiyama, Kohei Taniguchi, Nobuhisa Matsuhashi, Toshihiro Tajirika, Manabu Futamura, Tomoaki Takai, Yukihiro Akao, Kazuhiro Yoshida. MiR‐133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle‐splicer polypyrimidine tract‐binding protein 1. Cancer Science 2016; 107(12): 1767 doi: 10.1111/cas.13091
|
| 59 |
Shuting Han, Joshua K. Tay, Celestine Jia Ling Loh, Axel Jun Ming Chu, Joe Poh Sheng Yeong, Chwee Ming Lim, Han Chong Toh. Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.734293
|
| 60 |
JUAN JIANG, BO YI, CHUNXIANG QIN, SIQING DING, WEI CAO. Upregulation of microRNA-27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2-mediated ERK signaling. Molecular Medicine Reports 2016; 13(3): 2267 doi: 10.3892/mmr.2016.4779
|
| 61 |
Yushuai Mi, Dongyuan Zhang, Weiliang Jiang, Junyong Weng, Chongzhi Zhou, Kejian Huang, Huamei Tang, Yang Yu, Xisheng Liu, Weiyingqi Cui, Meng Zhang, Xiaofeng Sun, Zongguang Zhou, Zhihai Peng, Senlin Zhao, Yugang Wen. miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Letters 2017; 389: 11 doi: 10.1016/j.canlet.2016.12.033
|
| 62 |
Leila Jamali, Roghayeh Tofigh, Sara Tutunchi, Ghodratollah Panahi, Fatemeh Borhani, Saeedeh Akhavan, Parisa Nourmohammadi, Sayyed M.H. Ghaderian, Milad Rasouli, Hamed Mirzaei. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. Journal of Cellular Physiology 2018; 233(11): 8538 doi: 10.1002/jcp.26850
|
| 63 |
Weihong Sun, Changqing Jiang, Ying Ji, Chao Xiao, Haiping Song, Zhenbo Xu. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8853269
|
| 64 |
Shuwei Wang, Jun Hu, Dongsheng Zhang, Juan Li, Qiang Fei, Yueming Sun. Prognostic role of microRNA-31 in various cancers: a meta-analysis. Tumor Biology 2014; 35(11): 11639 doi: 10.1007/s13277-014-2492-x
|
| 65 |
Francesco Vasuri, Michela Visani, Giorgia Acquaviva, Thomas Brand, Michelangelo Fiorentino, Annalisa Pession, Giovanni Tallini, Antonia D’Errico, Dario de Biase. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(25): 2647-2660 doi: 10.3748/wjg.v24.i25.2647
|
| 66 |
Al-Alo KZK, Hiba R. Al-abodi, Lateef Al-Awsi Ghaidaa Raheem, Yasemin K. Alghanimi, Majida M.M. Alshammari, Seyede A. Mirforughi. Helicobacter pylori virulence factors expression affect epigenetic factors leading to gastrointestinal carcinoma. Reviews in Medical Microbiology 2020; 31(3): 117 doi: 10.1097/MRM.0000000000000203
|
| 67 |
Xuefeng Jiang, Zhe Wang. miR-16 targets SALL4 to repress the proliferation and migration of gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8997
|
| 68 |
Guan Li, Sheng Ao, Jianing Hou, Guoqing Lyu. Low expression of miR‑125a‑5p is associated with poor prognosis in patients with gastric cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10423
|
| 69 |
Gang Yin, PeiRong Tian, Amin BuHe, Wei Yan, TianXiong Li, ZhiPeng Sun. <p>LncRNA LINC00689 Promotes the Progression of Gastric Cancer Through Upregulation of ADAM9 by Sponging miR-526b-3p</p>. Cancer Management and Research 2020; : 4227 doi: 10.2147/CMAR.S231042
|
| 70 |
XUETING LIU, JUN CAI, YANJUN SUN, RENHUA GONG, DENGQUN SUN, XINGGUO ZHONG, SHITAO JIANG, XINMIAO HE, ENWU BAO, LIUSHENG YANG, YONGXIANG LI. MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells. Molecular Medicine Reports 2015; 12(3): 3944 doi: 10.3892/mmr.2015.3817
|
| 71 |
Luanna Munhoz Zabaglia, Mayara Luciana Sallas, Mônica Pezenatto Dos Santos, Wilson Aparecido Orcini, Rita Luiza Peruquetti, Dulce Helena Constantino, Elizabeth Chen, Marilia De Arruda Cardoso Smith, Spencer‐Luiz Marques Payão, Lucas Trevizani Rasmussen. Expression of miRNA‐146a, miRNA‐155, IL‐2, and TNF‐α in inflammatory response to Helicobacter pylori infection associated with cancer progression. Annals of Human Genetics 2018; 82(3): 135 doi: 10.1111/ahg.12234
|
| 72 |
Xingjie Shen, Xiaoyan Zhu, Peixin Hu, Tingting Ji, Ying Qin, Jingyu Zhu. Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis. Biochemical Genetics 2022; 60(5): 1567 doi: 10.1007/s10528-021-10165-5
|
| 73 |
Dhananjay Shukla, Saurabh Saxena, Pranav Kumar Prabhakar. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 115 doi: 10.1007/978-981-15-5471-1_8
|
| 74 |
Yeongdon Ju, Young Mi Seol, Jungho Kim, Hyunwoo Jin, Go-Eun Choi, Aelee Jang. Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer. International Journal of Molecular Sciences 2022; 23(11): 6041 doi: 10.3390/ijms23116041
|